Symbols / STAA Stock $27.45 +0.59% STAAR Surgical Company

Healthcare • Medical Instruments & Supplies • United States • NGM
STAA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Warren Foust
Exch · Country NGM · United States
Market Cap 1.37B
Enterprise Value 1.21B
Income -80.45M
Sales 239.44M
FCF (ttm) 14.61M
Book/sh 6.97
Cash/sh 3.79
Employees 921
Insider 10d —
IPO Feb 24, 1992
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 35.65
PEG 0.76
P/S 5.71
P/B 3.94
P/C —
EV/EBITDA -32.34
EV/Sales 5.05
Quick Ratio 3.53
Current Ratio 4.55
Debt/Eq 11.14
LT Debt/Eq —
EPS (ttm) -1.62
EPS next Y 0.77
EPS Growth —
Revenue Growth 18.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-13
Earnings (prior) 2026-03-03
ROA -5.95%
ROE -21.70%
ROIC —
Gross Margin 76.19%
Oper. Margin -18.87%
Profit Margin -33.60%
Shs Outstand 49.79M
Shs Float 26.94M
Insider Own 0.60%
Instit Own 114.50%
Short Float 26.35%
Short Ratio 4.99
Short Interest 7.49M
52W High 30.81
vs 52W High -10.91%
52W Low 15.59
vs 52W Low 76.07%
Beta 1.20
Impl. Vol. 73.73%
Rel Volume 0.65
Avg Volume 1.31M
Volume 846.18K
Target (mean) $21.11
Tgt Median $22.00
Tgt Low $16.00
Tgt High $27.00
# Analysts 9
Recom Hold
Prev Close $27.29
Price $27.45
Change 0.59%
About

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$21.11
Mean price target
2. Current target
$27.45
Latest analyst target
3. DCF / Fair value
$5.28
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$27.45
Low
$16.00
High
$27.00
Mean
$21.11

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main Wedbush Neutral → Neutral $26
2026-04-09 up Canaccord Genuity Hold → Buy $27
2026-03-05 main Wells Fargo Equal-Weight → Equal-Weight $16
2026-03-04 main Stifel Hold → Hold $18
2026-02-09 main Stifel Hold → Hold $19
2026-02-03 init Wedbush — → Neutral $26
2026-01-28 main Jefferies Buy → Buy $22
2026-01-16 main Canaccord Genuity Hold → Hold $22
2025-12-10 main Wells Fargo Equal-Weight → Equal-Weight $31
2025-12-10 main Canaccord Genuity Hold → Hold $31
2025-08-07 down Stifel Buy → Hold $28
2025-08-06 main Canaccord Genuity Hold → Hold $28
2025-08-05 down Sidoti & Co. Buy → Neutral $28
2025-07-16 main Mizuho Neutral → Neutral $18
2025-05-27 main Canaccord Genuity Hold → Hold $20
2025-05-21 reit Needham Hold → Hold —
2025-05-08 main Canaccord Genuity Hold → Hold $20
2025-04-21 init Wells Fargo — → Equal-Weight $17
2025-03-18 reit Stephens & Co. Equal-Weight → Equal-Weight $17
2025-02-27 reit Needham Hold → Hold —
News
RSS: Latest STAA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security — 670,213 $17.52 $12,266,545
2026-03-13 MICHNA MAGDA Officer — 23,773 — —
2026-03-13 FOUST WARREN Chief Executive Officer — 37,500 — —
2026-01-12 JIANG WEI Director — 20,967 — —
2026-01-09 BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security — 27,485 $22.05 $606,138
2026-01-08 BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security — 406,653 $21.01 $8,817,664
2025-11-21 BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security — 1,500,000 $26.42 $41,060,317
2025-11-12 JIANG WEI Director — 20,967 — —
2025-08-12 JIANG WEI Director — 20,967 — —
2025-04-10 BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security — 187,227 $15.08 $2,866,428
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
239.44
-23.72%
313.90
-2.64%
322.42
+13.37%
284.39
Operating Revenue
239.44
-23.72%
313.90
-2.64%
322.42
+13.37%
284.39
Cost Of Revenue
57.02
-23.27%
74.32
+6.53%
69.76
+14.35%
61.01
Reconciled Cost Of Revenue
57.02
-23.27%
74.32
+6.53%
69.76
+14.35%
61.01
Gross Profit
182.42
-23.86%
239.58
-5.17%
252.65
+13.10%
223.38
Operating Expense
228.37
-9.45%
252.19
+12.31%
224.55
+25.04%
179.58
Research And Development
40.05
-11.61%
45.32
+11.95%
40.48
+12.49%
35.98
Selling General And Administration
188.31
-8.97%
206.88
+12.39%
184.08
+28.19%
143.60
Selling And Marketing Expense
102.53
-12.35%
116.98
+4.67%
111.76
+25.77%
88.86
General And Administrative Expense
85.78
-4.58%
89.90
+24.31%
72.32
+32.11%
54.74
Other Gand A
85.78
-4.58%
89.90
+24.31%
72.32
+32.11%
54.74
Total Expenses
285.39
-12.59%
326.51
+10.94%
294.32
+22.33%
240.59
Operating Income
-45.95
-264.33%
-12.61
-144.88%
28.10
-35.85%
43.80
Total Operating Income As Reported
-91.71
-627.25%
-12.61
-144.88%
28.10
-35.85%
43.80
EBITDA
-37.22
-550.66%
-5.72
-117.22%
33.22
-31.24%
48.31
Normalized EBITDA
5.95
+390.76%
-2.04
-105.82%
35.13
-29.77%
50.02
Reconciled Depreciation
8.73
+26.66%
6.89
+34.48%
5.12
+13.64%
4.51
EBIT
-45.95
-264.33%
-12.61
-144.88%
28.10
-35.85%
43.80
Total Unusual Items
-43.16
-1074.53%
-3.67
-92.51%
-1.91
-11.83%
-1.71
Total Unusual Items Excluding Goodwill
-43.16
-1074.53%
-3.67
-92.51%
-1.91
-11.83%
-1.71
Special Income Charges
-45.77
0.00
0.00
—
Restructuring And Mergern Acquisition
45.77
0.00
0.00
—
Net Income
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Pretax Income
-82.26
-808.78%
-9.05
-126.86%
33.70
-26.03%
45.55
Net Non Operating Interest Income Expense
4.59
-22.28%
5.91
-15.39%
6.99
+185.38%
2.45
Net Interest Income
4.59
-22.28%
5.91
-15.39%
6.99
+185.38%
2.45
Interest Income Non Operating
4.59
-22.28%
5.91
-15.39%
6.99
+185.38%
2.45
Interest Income
4.59
-22.28%
5.91
-15.39%
6.99
+185.38%
2.45
Other Income Expense
-40.91
-1639.41%
-2.35
-69.57%
-1.39
-98.71%
-0.70
Other Non Operating Income Expenses
2.25
+70.29%
1.32
+153.45%
0.52
-48.27%
1.01
Gain On Sale Of Security
2.60
+170.83%
-3.67
-92.51%
-1.91
-11.83%
-1.71
Tax Provision
-1.81
-116.27%
11.16
-9.66%
12.35
+109.77%
5.89
Tax Rate For Calcs
0.00
-89.52%
0.00
-42.70%
0.00
+184.10%
0.00
Tax Effect Of Unusual Items
-0.95
-23.05%
-0.77
-10.31%
-0.70
-217.71%
-0.22
Net Income Including Noncontrolling Interests
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Net Income From Continuing Operation Net Minority Interest
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Net Income From Continuing And Discontinued Operation
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Net Income Continuous Operations
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Normalized Income
-38.23
-120.94%
-17.30
-176.72%
22.56
-45.19%
41.15
Net Income Common Stockholders
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Diluted EPS
-1.62
-295.12%
-0.41
-195.35%
0.43
-45.57%
0.79
Basic EPS
-1.62
-295.12%
-0.41
-193.18%
0.44
-45.68%
0.81
Basic Average Shares
49.57
+0.90%
49.12
+1.24%
48.52
+1.12%
47.99
Diluted Average Shares
49.57
+0.90%
49.12
-0.61%
49.43
+0.10%
49.38
Diluted NI Availto Com Stockholders
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Total Other Finance Cost
—
—
-6.99
-185.38%
-2.45
Line Item Trend 2025-12-31
Total Assets
451.68
Current Assets
311.55
Cash Cash Equivalents And Short Term Investments
187.54
Cash And Cash Equivalents
153.15
Other Short Term Investments
34.39
Receivables
54.31
Accounts Receivable
50.06
Gross Accounts Receivable
50.15
Allowance For Doubtful Accounts Receivable
-0.08
Taxes Receivable
4.24
Inventory
55.50
Raw Materials
10.24
Work In Process
8.51
Finished Goods
39.67
Prepaid Assets
13.83
Other Current Assets
0.37
Total Non Current Assets
140.13
Net PPE
102.93
Gross PPE
153.90
Accumulated Depreciation
-50.97
Properties
0.00
Machinery Furniture Equipment
63.56
Construction In Progress
30.34
Other Properties
0.77
Leases
59.23
Goodwill And Other Intangible Assets
32.49
Goodwill
1.79
Other Intangible Assets
30.70
Investments And Advances
—
Non Current Deferred Assets
3.37
Non Current Deferred Taxes Assets
3.37
Other Non Current Assets
1.35
Total Liabilities Net Minority Interest
107.49
Current Liabilities
68.50
Payables And Accrued Expenses
28.44
Payables
13.77
Accounts Payable
11.57
Other Payable
0.89
Current Accrued Expenses
14.66
Employee Benefits
6.38
Pensionand Other Post Retirement Benefit Plans Current
9.42
Total Tax Payable
1.30
Income Tax Payable
1.30
Current Debt And Capital Lease Obligation
5.87
Current Capital Lease Obligation
5.87
Other Current Liabilities
24.77
Total Non Current Liabilities Net Minority Interest
38.99
Long Term Debt And Capital Lease Obligation
32.48
Long Term Capital Lease Obligation
32.48
Long Term Provisions
0.04
Non Current Pension And Other Postretirement Benefit Plans
6.38
Non Current Deferred Liabilities
0.09
Non Current Deferred Taxes Liabilities
0.00
Stockholders Equity
344.18
Common Stock Equity
344.18
Capital Stock
0.50
Common Stock
0.50
Share Issued
49.78
Ordinary Shares Number
49.40
Treasury Shares Number
0.38
Additional Paid In Capital
504.68
Retained Earnings
-148.02
Gains Losses Not Affecting Retained Earnings
-6.51
Treasury Stock
6.46
Other Equity Adjustments
-6.51
Total Equity Gross Minority Interest
344.18
Total Capitalization
344.18
Working Capital
243.04
Invested Capital
344.18
Total Debt
38.35
Capital Lease Obligations
38.35
Net Tangible Assets
311.70
Tangible Book Value
311.70
Available For Sale Securities
—
Current Provisions
—
Inventories Adjustments Allowances
-2.93
Investmentin Financial Assets
—
Line Of Credit
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-34.23
-317.68%
15.72
+7.75%
14.59
-59.14%
35.72
Cash Flow From Continuing Operating Activities
-34.23
-317.68%
15.72
+7.75%
14.59
-59.14%
35.72
Net Income From Continuing Operations
-80.45
-298.10%
-20.21
-194.66%
21.35
-46.18%
39.66
Depreciation Amortization Depletion
8.73
+26.66%
6.89
+34.48%
5.12
+13.64%
4.51
Depreciation
8.32
+20.72%
6.89
+34.83%
5.11
+14.06%
4.48
Amortization Cash Flow
0.41
0.00
-100.00%
0.01
-53.57%
0.03
Depreciation And Amortization
8.73
+26.66%
6.89
+34.48%
5.12
+13.64%
4.51
Amortization Of Intangibles
0.41
0.00
-100.00%
0.01
-53.57%
0.03
Other Non Cash Items
3.57
+1.85%
3.51
+11.26%
3.15
+6610.64%
0.05
Pension And Employee Benefit Expense
-0.25
-1057.69%
0.03
+102.72%
-0.96
-1903.77%
0.05
Stock Based Compensation
30.59
+12.41%
27.21
+15.71%
23.52
+15.44%
20.37
Provisionand Write Offof Assets
9.00
+193.29%
3.07
-44.36%
5.51
+65.29%
3.34
Asset Impairment Charge
15.40
0.00
-100.00%
0.15
0.00
Deferred Tax
-2.92
-181.23%
3.59
+9.99%
3.26
+244.81%
-2.25
Deferred Income Tax
-2.92
-181.23%
3.59
+9.99%
3.26
+244.81%
-2.25
Operating Gains Losses
-1.63
-194.94%
1.72
+294.79%
-0.88
-848.31%
0.12
Gain Loss On Sale Of PPE
-1.38
-181.70%
1.69
+2220.55%
0.07
+12.31%
0.07
Change In Working Capital
-16.33
-82.14%
-8.96
+79.67%
-44.09
-52.69%
-28.88
Change In Receivables
27.83
+68.76%
16.49
+150.34%
-32.76
-67.13%
-19.60
Changes In Account Receivables
27.83
+68.76%
16.49
+150.34%
-32.76
-67.13%
-19.60
Change In Inventory
-16.98
-69.81%
-10.00
+30.37%
-14.36
-80.80%
-7.94
Change In Prepaid Assets
-1.35
+32.60%
-2.01
-99.21%
-1.01
+60.49%
-2.55
Change In Payables And Accrued Expense
-5.51
-7442.67%
0.07
+110.70%
-0.70
-138.84%
1.80
Change In Payable
-5.51
-7442.67%
0.07
+110.70%
-0.70
-138.84%
1.80
Change In Account Payable
-5.51
-7442.67%
0.07
+110.70%
-0.70
-138.84%
1.80
Change In Other Current Assets
-15.76
-18.02%
-13.36
-455.15%
-2.41
—
Change In Other Current Liabilities
-4.56
-2596.45%
-0.17
-102.37%
7.14
+1308.12%
-0.59
Investing Cash Flow
46.34
+178.25%
-59.22
-179.65%
74.35
+147.54%
-156.38
Cash Flow From Continuing Investing Activities
46.34
+178.25%
-59.22
-179.65%
74.35
+147.54%
-156.38
Net PPE Purchase And Sale
-5.82
+75.12%
-23.39
-28.62%
-18.19
-0.44%
-18.11
Purchase Of PPE
-5.82
+75.12%
-23.39
-28.62%
-18.19
-0.44%
-18.11
Capital Expenditure
-5.82
+75.12%
-23.39
-28.62%
-18.19
-0.44%
-18.11
Net Investment Purchase And Sale
52.16
+245.60%
-35.82
-138.71%
92.53
+166.92%
-138.27
Purchase Of Investment
-75.36
+6.08%
-80.24
-53.38%
-52.31
+66.41%
-155.75
Sale Of Investment
127.52
+187.10%
44.42
-69.34%
144.85
+728.65%
17.48
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
-4.55
-179.58%
5.72
-22.81%
7.42
-10.63%
8.30
Cash Flow From Continuing Financing Activities
-4.55
-179.58%
5.72
-22.81%
7.42
-10.63%
8.30
Net Issuance Payments Of Debt
-0.04
+74.55%
-0.17
-2.48%
-0.16
-27.78%
-0.13
Repayment Of Debt
-0.04
+74.55%
-0.17
-2.48%
-0.16
-27.78%
-0.13
Long Term Debt Payments
-0.04
+74.55%
-0.17
-2.48%
-0.16
-27.78%
-0.13
Net Long Term Debt Issuance
-0.04
+74.55%
-0.17
-2.48%
-0.16
-27.78%
-0.13
Short Term Debt Payments
—
—
0.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
-7.98
-430.81%
-1.50
+28.29%
-2.10
-209700.00%
0.00
Common Stock Payments
-7.98
-430.30%
-1.50
+28.23%
-2.10
0.00
Repurchase Of Capital Stock
-7.98
-430.30%
-1.50
+28.23%
-2.10
0.00
Proceeds From Stock Option Exercised
3.46
-53.13%
7.39
-23.57%
9.67
+14.84%
8.42
Net Other Financing Charges
—
—
—
—
Changes In Cash
7.55
+120.00%
-37.77
-139.20%
96.36
+185.75%
-112.36
Effect Of Exchange Rate Changes
1.44
+229.34%
-1.11
-650.00%
0.20
+123.43%
-0.86
Beginning Cash Position
144.16
-21.24%
183.04
+111.65%
86.48
-56.70%
199.71
End Cash Position
153.15
+6.24%
144.16
-21.24%
183.04
+111.65%
86.48
Free Cash Flow
-40.05
-422.23%
-7.67
-113.38%
-3.59
-120.41%
17.61
Interest Paid Supplemental Data
0.12
+40.23%
0.09
+16.00%
0.07
+44.23%
0.05
Income Tax Paid Supplemental Data
—
10.98
+286.01%
2.84
-57.12%
6.63
Amortization Of Securities
-0.20
+81.85%
-1.09
+56.38%
-2.50
-108.76%
-1.20
Common Stock Issuance
0.00
+50.00%
0.00
+100.00%
0.00
+0.00%
0.00
Issuance Of Capital Stock
0.00
+50.00%
0.00
+100.00%
0.00
+0.00%
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category